365Telugu.com online news,India,November 19th, 2024: Indegene, a digital-first life sciences commercialization company, has announced the opening of a new center in Hyderabad. This move aims to strengthen its global delivery operations and address the increasing business demands from across the globe.
With the pharmaceutical industry under growing pressure to innovate and adapt, this new center will play a crucial role in helping companies accelerate their transformation. This aligns with Indegene’s mission to enable healthcare organizations to be future-ready by combining deep medical expertise with purpose-built technology.
India is rapidly emerging as a critical hub for global pharmaceutical companies, thanks to its vast pool of skilled medical and technology talent. These companies are increasingly seeking a partner with core domain expertise and life sciences-contextualized technology to help scale operations in a non-linear, technology-driven manner.
“Indegene has a proven track record of helping global pharmaceutical companies reimagine their commercialization processes, driving innovation with GenAI, and fully integrating these capabilities into their business operations,” said Manish Gupta, Chairman and CEO of Indegene.
“Through this new center, we are strengthening our capabilities to assist life sciences companies in modernizing and transforming their commercial, medical, and clinical operations, using our purpose-built technology.”
Indegene’s leadership in life sciences commercialization has been further recognized by the Everest Group, which named the company a Leader in its 2024 Life Sciences Digital Services Specialist PEAK Matrix® Assessment.
Additionally, HFS Research recently recognized Indegene as a Leader in GenAI in Life Sciences, further validating the company’s commitment to innovation and excellence in the industry.
With six operational hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies, many emerging biotech firms, and medical device companies.
This expansive global footprint highlights Indegene’s ability to scale and meet the evolving needs of leading pharmaceutical organizations across various markets.